Skip to main content
Clinical Trials/JPRN-UMIN000050449
JPRN-UMIN000050449
Completed
未知

Effects of a Test Food for Cognitive Function - Effects of a Test Food for Cognitive Function

Morinaga & Co., Ltd.0 sites18 target enrollmentApril 1, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
/A(healthy adults)
Sponsor
Morinaga & Co., Ltd.
Enrollment
18
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 1, 2023
End Date
March 11, 2022
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Morinaga & Co., Ltd.

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Individuals using medical products. 2\) Individuals with dementia. 3\) Individuals who used a drug for treatment of disease in the past 1 month. 4\) Individuals who have a history of serious hepatopathy, kidney damage, heart disease, hematological and blood disease. 5\) Individuals who contract or have a history of serious gastrointestinal disease. 6\) Individuals with serious anemia. 7\) Individuals who contract or have a history of food allergy. (milk) 8\) Females who are or are possibly pregnant, or are lactating. 9\) Individuals who have an addiction to alcohol or a mental illness. 10\) Individuals who are a smoker. 11\) Individuals whose life style will change during the test period. 12\) Individuals with probable seasonal allergy, such as pollinosis, during the test period.(Betulaceae: alder, oba alnus firma, shirakaba, Taxodiaceae: cryptomeria, hinoki cypress, Asteraceae: ragweed, Artemisia vulgaris indica, Gramineae:Dactylis glomerata, Phleum pratense) 13\) Individuals who had a habit to ingest health\-promoting foods, foods for specified health uses, health foods, or supplements in the past 3 months or will ingest those foods during the test period. 14\) Individuals who had a habit to ingest foods claiming to improve cognitive function, foods for specified health uses, health foods, or supplements in the past 3 months or will ingest those foods during the test period. 15\) Individuals who have a habit to use drug claiming to improve cognitive function in the past 3 months. 16\) Individuals who conducted hormone replacement therapy in the past 6 months or have a history of conducting hormone replacement therapy. 17\) Individuals who were hospitalized and received treatment in the past 6 months, or will be hospitalized during the test period. 18\) Individuals who participated in other clinical studies in the past 1 months. 19\) Individuals having not completed two doses of COVID\-19 vaccine. 20\) Individuals judged inappropriate for the study by the principal.

Outcomes

Primary Outcomes

Not specified

Similar Trials